Clinical features and management of pouchitis in Japanese ulcerative colitis patients

Surgery Today

Volumn 43, Issue 9, 2013, Pages 1049-1057

  Uchino, Motoi ^a   Ikeuchi, Hiroki ^a   Matsuoka, Hiroki ^a   Bando, Toshihiro ^a   Takesue, Yoshio ^a   Tomita, Naohiro ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Pouch surgery; Pouchitis; Refractory pouchitis; Restorative proctocolectomy; Ulcerative colitis

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; CORTICOSTEROID; INFLIXIMAB; METRONIDAZOLE; PREDNISOLONE; TACROLIMUS;

ACUTE POUCHITIS; ADULT; AGE; ARTICLE; CANCER STAGING; CHRONIC POUCHITIS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DYSPLASIA; FEMALE; HUMAN; ILEITIS; INCIDENCE; JAPANESE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; POSTOPERATIVE PERIOD; POUCH SURGERY; PREOPERATIVE EVALUATION; PROCTOCOLECTOMY; RISK ASSESSMENT; RISK FACTOR; TREATMENT INDICATION; ULCERATIVE COLITIS;

ACUTE DISEASE; ADOLESCENT; ADULT; AGE FACTORS; AGE OF ONSET; AGED; ANTI-BACTERIAL AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CHRONIC DISEASE; CIPROFLOXACIN; COLITIS, ULCERATIVE; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNE SYSTEM DISEASES; INCIDENCE; JAPAN; LOGISTIC MODELS; MEGACOLON, TOXIC; METRONIDAZOLE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; POUCHITIS; PROCTOCOLECTOMY, RESTORATIVE; RISK; RISK FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 84882239586     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-012-0377-4     Document Type: Article

References (27)

1. Fazio VW, Ziv Y, Church JM, Oakley JR, Lavery IC, Milsom JW, Schroeder TK. Ileal pouch-anal anastomosis: complications and function in 1005 patients. Ann Surg. 1995;222:120-7.
2. Penna C, Dozois R, Tremaine W, Sandborn W, LaRusso N, Schleck C, Ilstrup D. Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. Gut. 1996;38:234-9.
3. Hurst RD, Molinari M, Chung TP, Rubin M, Michelassi F. Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy. Arch Surg. 1996;131:497-500.
4. Stahlberg D, Gullberg K, Liljeqvist L, Hellers G, Löfberg R. Pouchitis following pelvic pouch operation for ulcerative colitis. Incidence, cumulative risk, and risk factors. Dis Colon Rectum. 1996;39:1012-8.
5. de Paiva NM, Ayrizono ML, Milanski M, Coope A, Oliveira LM, Fagundes JJ, Velloso LA, Coy CS, Leal RF. Differential expression of TLR2, TLR4 and JNK in mucosa of ileal pouches for ulcerative colitis. Is there a role for bacterial antigen pathway in asymptomatic patients? Int J Clin Exp Med. 2011;4:179-86.
6. Okita Y, Miki C, Yoshiyama S, Otake K, Araki T, Uchida K, Kusunoki M. Neutrophil dysfunction in steroid-overdosed patients with ulcerative colitis: potential relevance of macrophage migration inhibitory factor to increased postoperative morbidity. Surg Today. 2011;41:1504-11.
7. Ikeuchi H, Nakano H, Uchino M, Nakamura M, Yanagi H, Noda M, Yamamura T. Incidence and therapeutic outcome of pouchitis for ulcerative colitis in Japanese patients. Dig Surg. 2004;21:197-201.
8. Sandborn WJ, Tremaine WJ, Batts KP, Pemberton JH, Phillips SF. Pouchitis after ileal pouch-anal anastomosis: a pouchitis disease activity index. Mayo Clin Proc. 1994;69:409-15.
9. Sandborn WJ. Pouchitis: risk factors, frequency, natural history, classification and public health prospective. In: McLeod RS, Martin F, Sutherland LR, Wallace JL, Williams CN, editors. Trends in Inflammatory Bowel Disease 1996. Lancaster: Kluwer; 1997. p. 51-63.
10. Shen B. Diagnosis and management of patients with pouchitis. Drugs. 2003;65:453-61.
11. Heuschen UA, Allemeyer EH, Hinz U, Autschbach F, Uehlein T, Herfarth C, Heuschen G. Diagnosing pouchitis: comparative validation of two scoring system in routine follow-up. Dis Colon Rectum. 2002;45:776-86.
12. Truelove SC, Witts LF. Cortisone in ulcerative colitis: final report on a therapeutic trial. BMJ. 1995;2:1041-8.
13. Hanauer S. Inflammatory bowel disease. N Engl J Med. 1996;334:841-8.
14. Mahadadevan U, Sandborn WJ. Diagnosis and management of pouchitis. Gastroenterology. 2003;124:1636-50.
15. Lipman JM, Kiran RP, Shen B, Remzi F, Fazio VW. Perioperative factors during ileal pouch-anal anastomosis predict pouchitis. Dis Colon Rectum. 2011;54:311-7.
16. Yantiss RK, Sapp HL, Farraye FA, El-Zammar O, O'Brien MJ, Fruin AB, Stucchi AF, Brien TP, Becker JM, Odze RD. Histologic predictors of pouchitis in patients with chronic ulcerative colitis. Am J Surg Pathol. 2004;28:999-1006.
17. Suzuki H, Ogawa H, Shibata C, Haneda S, Watanabe K, Takahashi K, Funayama Y, Sasaki I. The long-term clinical course of pouchitis after total proctocolectomy and IPAA for ulcerative colitis. Dis Colon Rectum. 2012;55:330-6.
18. Shen B, Achkar JP, Lashner BA, Ormsby AH, Brzezinski A, Soffer EE, Remzi FH, Bevins CL, Fazio VW. Irritable pouch syndrome: a new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis. Am J Gastroenterol. 2002;97:972-7.
19. Kohyama M, Takesue Y, Ohge H, Murakami Y, Shimamoto F, Sueda T. Pouchitis disease activity index (PDAI) does not predict patients with symptoms of pouchitis who will respond to antibiotics. Surg Today. 2009;39:962-8.
20. Shen B. Diagnosis and treatment of patients with pouchitis. Drugs. 2003;63:453-61.
21. Shen B, Achkar JP, Lashner BA, Ormsby AH, Remzi FH, Brzezinski A, Bevins CL, Bambrick ML, Seidner DL, Fazio VW. A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis. Inflamm Bowel Dis. 2001;7:301-5.
22. Pardi DS, D'Haens G, Shen B, Campbell S, Gionchetti P. Clinical guidelines for the management of pouchitis. Inflamm Bowel Dis. 2009;15:1424-31.
23. Navaneethan U, Shen B. Pros and cons of antibiotic therapy for pouchitis. Expert Rev Gastroenterol Hepatol. 2009;3:547-59.
24. Winter TA, Dalton HR, Merrett MN, Campbell A, Jewell DP. Cyclosporin A retention enemas in refractory pouchitis and ileitis. Scand J Gastroenterol. 1993;28:701-4.
25. Hait EJ, Bousvaros A, Schuman M, Shamberger RC, Lillehei CW. Pouch outcomes among children with ulcerative colitis treated with calcineurin inhibitors before ileal pouch anal anastomosis surgery. J Pediatr Surg. 2007;42:31-34; discussion 34-35.
26. Calabrese C, Gionchetti P, Rizzello F, Liguori G, Gabusi V, Tambasco R, Poggioli G, Pierangeli F, Campieri M, Di Febo G. Short-term treatment with infliximab in chronic refractory pouchitis and ileitis. Aliment Pharmacol Ther. 2008;27:759-64.
27. Viscido A, Habib FI, Kohn A, Papi C, Marcheggiano A, Pimpo MT, Vernia P, Cadau G, Caprilli R. Infliximab in refractory pouchitis complicated by fistulae following ileo-anal pouch for ulcerative colitis. Aliment Pharmacol Ther. 2003;17:126312-71.